LEXARIA BIOSCIENCE CORP. Increase (Decrease) in Prepaid Expense and Other Assets
LEXARIA BIOSCIENCE CORP. (LEXX) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$733.74 thousand for the 9-month period ending 2026-05-31, per its 10-Q filed 2026-07-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-07-13
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-05-31 was -$85.08K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-02-28 was -$391.74K, a 196.42% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-11-30 was -$256.92K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-08-31 was $309.16K, a 61.75% decline year-over-year.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for fiscal 2025 was -$55.31K, a 108.63% decline from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $641.03K.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for fiscal 2018 was $44.04K, a 147.19% increase from fiscal 2017.
- LEXARIA BIOSCIENCE CORP. increase (decrease) in prepaid expense and other assets for fiscal 2017 was $17.82K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 1 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 10 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-05-31 | -$85.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | -$476.82K derived: sum of 2 quarters · filed 2026-07-13 | -$733.74K 10-Q · filed 2026-07-13 | -$424.58K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2026-02-28 | -$391.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | -$648.66K 10-Q · filed 2026-04-13 | -$339.50K derived: sum of 3 quarters · filed 2026-04-13 | -$366.54K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2025-11-30 | -$256.92K 10-Q · filed 2026-01-13 | $52.24K derived: sum of 2 quarters · filed 2026-01-13 | $25.20K derived: sum of 3 quarters · filed 2026-07-13 | $431.46K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2025-08-31 | $309.16K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $282.12K derived: sum of 2 quarters · filed 2026-07-13 | $688.38K derived: sum of 3 quarters · filed 2026-07-13 | -$55.31K 10-K · filed 2025-11-28 | |||
| 2025-05-31 | -$27.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-07-13 | $379.23K derived: sum of 2 quarters · filed 2026-07-13 | -$364.47K 10-Q · filed 2026-07-13 | $443.80K derived: sum of 4 quarters · filed 2026-07-13 | |||
| 2025-02-28 | $406.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-04-13 | -$337.43K 10-Q · filed 2026-04-13 | $470.84K derived: sum of 3 quarters · filed 2026-04-13 | ||||
| 2024-11-30 | -$743.70K 10-Q · filed 2026-01-13 | $64.58K derived: sum of 2 quarters · filed 2026-01-13 | |||||
| 2024-08-31 | $808.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-28 | $641.03K 10-K · filed 2025-11-28 | |||||
| 2024-05-31 | -$167.24K 10-Q · filed 2025-07-14 | ||||||
| 2021-12-31 | $600.00K 10-Q · filed 2022-07-14 | ||||||
| 2018-08-31 | $31.85K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $16.89K derived: sum of 2 quarters · filed 2018-11-14 | $135.59K derived: sum of 3 quarters · filed 2018-11-14 | $44.04K 10-K · filed 2018-11-14 | |||
| 2018-05-31 | -$14.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | $103.74K derived: sum of 2 quarters · filed 2018-07-13 | $12.19K 10-Q · filed 2018-07-13 | $57.36K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2018-02-28 | $118.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | $27.16K 10-Q · filed 2018-04-12 | $72.33K derived: sum of 3 quarters · filed 2018-11-14 | $63.79K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-11-30 | -$91.55K 10-Q · filed 2018-01-12 | -$46.38K derived: sum of 2 quarters · filed 2018-11-14 | -$54.92K derived: sum of 3 quarters · filed 2018-11-14 | -$75.77K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-08-31 | $45.17K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | $36.63K derived: sum of 2 quarters · filed 2018-11-14 | $15.79K derived: sum of 3 quarters · filed 2018-11-14 | $17.82K 10-K · filed 2018-11-14 | |||
| 2017-05-31 | -$8.54K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-07-13 | -$29.38K derived: sum of 2 quarters · filed 2018-07-13 | -$27.35K 10-Q · filed 2018-07-13 | $32.22K derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-02-28 | -$20.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-04-12 | -$18.81K 10-Q · filed 2018-04-12 | $40.76K derived: sum of 3 quarters · filed 2018-11-14 | ||||
| 2016-11-30 | $2.03K 10-Q · filed 2018-01-12 | $61.60K derived: sum of 2 quarters · filed 2018-11-14 | |||||
| 2016-08-31 | $59.57K derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-14 | -$26.19K 10-K · filed 2018-11-14 | |||||
| 2016-05-31 | -$85.76K 10-Q · filed 2017-07-14 | ||||||
| 2016-02-29 | -$103.22K 10-Q · filed 2017-04-14 | ||||||
| 2015-11-30 | -$65.80K 10-Q · filed 2017-01-13 | -$195.01K derived: sum of 2 quarters · filed 2017-01-13 | |||||
| 2015-08-31 | -$129.21K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | -$96.83K 10-K · filed 2016-11-29 | |||||
| 2015-05-31 | $32.38K 10-Q · filed 2016-07-13 | ||||||
| 2015-02-28 | -$108.71K 10-Q · filed 2016-04-13 | ||||||
| 2014-11-30 | -$94.19K 10-Q · filed 2016-01-08 | -$454.08K derived: sum of 2 quarters · filed 2016-01-08 | |||||
| 2014-08-31 | -$359.89K derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-27 | $58.14K 10-KT · filed 2014-12-09 | $58.14K 10-K · filed 2015-11-27 | ||||
| 2014-07-31 | $34.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $36.83K derived: sum of 2 quarters · filed 2014-11-14 | $40.67K 10-Q · filed 2014-11-14 | ||||
| 2014-05-31 | $418.03K 10-Q · filed 2015-07-14 | ||||||
| 2014-04-30 | $2.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $6.60K 10-Q · filed 2014-06-12 | |||||
| 2014-02-28 | $1.51K 10-Q · filed 2015-04-14 | ||||||
| 2014-01-31 | $3.84K 10-Q · filed 2014-03-12 | ||||||
| 2013-11-30 | $1.51K 10-Q · filed 2015-01-14 | ||||||
| 2013-10-31 | -$1.47K derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | -$2.95K derived: sum of 2 quarters · filed 2014-12-09 | -$4.42K derived: sum of 3 quarters · filed 2014-12-09 | $32.00 10-KT · filed 2014-12-09 | |||
| 2013-08-31 | $1.51K 10-KT · filed 2014-12-09 | ||||||
| 2013-07-31 | -$1.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | -$2.95K derived: sum of 2 quarters · filed 2014-11-14 | $1.51K 10-Q · filed 2014-11-14 | $302.63K derived: sum of 4 quarters · filed 2014-11-14 | |||
| 2013-04-30 | -$1.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-12 | $2.98K 10-Q · filed 2014-06-12 | $304.10K derived: sum of 3 quarters · filed 2014-06-12 | $113.35K derived: sum of 4 quarters · filed 2014-06-12 | |||
| 2013-01-31 | $4.46K 10-Q · filed 2014-03-12 | $305.58K derived: sum of 2 quarters · filed 2014-03-12 | $114.82K derived: sum of 3 quarters · filed 2014-03-12 | $116.16K derived: sum of 4 quarters · filed 2014-03-12 | |||
| 2012-10-31 | $301.12K derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-24 | $110.37K derived: sum of 2 quarters · filed 2014-01-24 | $111.70K derived: sum of 3 quarters · filed 2014-01-24 | -$33.77K 10-K · filed 2014-01-24 | |||
| 2012-07-31 | -$190.75K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-10 | -$189.42K derived: sum of 2 quarters · filed 2013-09-10 | -$334.88K 10-Q · filed 2013-09-10 | -$337.06K derived: sum of 4 quarters · filed 2013-09-10 | |||
| 2012-04-30 | $1.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-12 | -$144.13K 10-Q · filed 2013-06-12 | -$146.31K derived: sum of 3 quarters · filed 2013-06-12 | -$148.44K derived: sum of 4 quarters · filed 2013-06-12 | |||
| 2012-01-31 | -$145.47K 10-Q · filed 2013-03-13 | -$147.65K derived: sum of 2 quarters · filed 2013-03-13 | -$149.78K derived: sum of 3 quarters · filed 2013-03-13 | -$152.16K derived: sum of 4 quarters · filed 2013-03-13 | |||
| 2011-10-31 | -$2.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-29 | -$4.31K derived: sum of 2 quarters · filed 2013-01-29 | -$6.69K derived: sum of 3 quarters · filed 2013-01-29 | -$241.00 10-K · filed 2013-01-29 | $304.70K 10-K · filed 2012-01-30 | ||
| 2011-07-31 | -$2.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-12 | -$4.51K derived: sum of 2 quarters · filed 2012-09-12 | $1.94K 10-Q · filed 2012-09-12 | -$402.00 derived: sum of 4 quarters · filed 2012-09-12 | |||
| 2011-04-30 | -$2.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-07 | $4.07K 10-Q · filed 2012-06-07 | $1.74K derived: sum of 3 quarters · filed 2012-06-07 | ||||
| 2011-01-31 | $6.45K 10-Q · filed 2012-03-13 | $4.11K derived: sum of 2 quarters · filed 2012-03-13 | |||||
| 2010-10-31 | -$2.34K derived: 10-K 12 month − 10-Q 9 month · filed 2012-01-30 | $2.34K 10-K · filed 2012-01-30 | |||||
| 2010-07-31 | $4.68K 10-Q · filed 2011-09-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |